The kids are alright — on GLP-1s, that is.

A new study found that blockbuster treatments like Mounjaro and Zepbound can dramatically lower blood sugar and body weight in children as young as 10 with Type 2 diabetes.

The data could help pave the way for younger patients to access the shots, as drugmaker Eli Lilly seeks to expand its approval beyond adults. And the stakes couldn’t be higher. 3

In 2002, 9 out of every 100,000 young Americans were diagnosed with Type 2 diabetes. By 2018, that number had doubled to 18 per 100,000, according to the CDC .

If the trend continues, the number of children and adolescents with the chronic disease is projected to soar from 28,000 in 2017 to 220,000 by 2060.

“Type 2 diabetes in children and teens is increasing at an alarming rate ,

See Full Page